Order Article Reprints

Hirao M, Sugimori H, Igarashi A, Yatsuhashi H, Satoh T, Ikeda S, Masaki N, Yotsuyanagi H, Takura T, Yoda T, et al. Longitudinal Changes in Utility Scores and Health-Related Quality of Life During Interferon-Free Direct-Acting Antiviral Therapy for Chronic Hepatitis C in Japan: Implications for Cost–Utility Analysis. Livers. 2026; 6(4):78. https://doi.org/10.3390/livers6040078

Hirao, Maki, Hiroki Sugimori, Ataru Igarashi, Hiroshi Yatsuhashi, Toshihiko Satoh, Shunya Ikeda, Naohiko Masaki, Hiroshi Yotsuyanagi, Tomoyuki Takura, Takeshi Yoda, and et al. 2026. "Longitudinal Changes in Utility Scores and Health-Related Quality of Life During Interferon-Free Direct-Acting Antiviral Therapy for Chronic Hepatitis C in Japan: Implications for Cost–Utility Analysis" Livers 6, no. 4: 78. https://doi.org/10.3390/livers6040078

Hirao, M., Sugimori, H., Igarashi, A., Yatsuhashi, H., Satoh, T., Ikeda, S., Masaki, N., Yotsuyanagi, H., Takura, T., Yoda, T., Akazawa, M., Suka, M., Ito, N., Odajima, T., & Hirao, T. (2026). Longitudinal Changes in Utility Scores and Health-Related Quality of Life During Interferon-Free Direct-Acting Antiviral Therapy for Chronic Hepatitis C in Japan: Implications for Cost–Utility Analysis. Livers, 6(4), 78. https://doi.org/10.3390/livers6040078